Cambridge Associates’s Vanguard Intermediate-Term Bond ETF BIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,583
Closed -$1.01M 45
2022
Q4
$1.01M Buy
+13,583
New +$1.01M 0.08% 39
2017
Q1
Sell
-12,917
Closed -$1.07M 33
2016
Q4
$1.07M Buy
+12,917
New +$1.1M 0.23% 28

Other funds holding BIV

Cambridge Associates's BIV Position: Q1 2023 in Review

Cambridge Associates sold out of Vanguard Intermediate-Term Bond ETF (BIV) in Q1 2023, closing a stake of 13,583 shares — an estimated $1.01M sold.

Cambridge Associates first reported a position in BIV in Q4 2016 and held it in 2 quarters. The position peaked at $1.07M in Q4 2016. 703 funds tracked by Wall St. Rank hold BIV as of Q1 2023.

  • Cambridge Associates reported no remaining Vanguard Intermediate-Term Bond ETF position as of Q1 2023 after selling out during the quarter.
  • Cambridge Associates sold 13,583 Vanguard Intermediate-Term Bond ETF shares in Q1 2023, an estimated $1.01M.
  • Cambridge Associates first reported a position in Vanguard Intermediate-Term Bond ETF in Q4 2016 and held it in 2 quarters.
  • Cambridge Associates's Vanguard Intermediate-Term Bond ETF position peaked at $1.07M in Q4 2016.
  • 703 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Bond ETF as of Q1 2023.

Based on Cambridge Associates's 13F filing for Q1 2023, filed 12 May 2023.